ClinConnect ClinConnect Logo
Search / Trial NCT05786001

Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia

Launched by TAMPERE UNIVERSITY · Mar 23, 2023

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Hyperspectral Imaging Thermal Imaging Angiosomes Clti Diabetes

ClinConnect Summary

This clinical trial is investigating a new way to assess blood flow in the legs for patients with a serious condition called Chronic Limb-Threatening Ischemia (CLTI). The researchers will use special imaging techniques, including hyperspectral and thermal imaging, to look at how well blood is circulating and how much oxygen is in the lower limbs of both healthy individuals and those with CLTI. The goal is to improve the methods used for screening and diagnosing this condition, which can lead to severe pain and even limb loss if not treated.

If you are over 50 years old and have been diagnosed with CLTI, or if you are over 50 and do not have any heart or blood vessel diseases, you may be eligible to participate. There’s also a group for younger, healthy individuals aged 18 to 50 with no history of heart issues. Participants can expect to undergo noninvasive tests that do not involve any needles or surgery. It’s important to note that you would need to be able to understand the study and agree to participate. This study is currently recruiting, and your involvement could help researchers find better ways to diagnose and manage CLTI in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • for CLTI patients age \>50
  • for age control group age \>50 and not diagnosed with cardiovascular diseases. 0.9 \< ABI \< 1.3
  • for healthy group 18 \<= age \<= 50 and no history of cardiovascular disease
  • volunteering for study
  • Exclusion Criteria:
  • inability to give informed consent
  • denial

About Tampere University

Tampere University, a leading research institution in Finland, is dedicated to advancing scientific knowledge and innovation through rigorous clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in health sciences, engineering, and social sciences to conduct impactful research that addresses pressing health challenges. Tampere University is committed to ethical research practices and fostering partnerships with healthcare providers and industry stakeholders to translate findings into meaningful clinical applications, ultimately enhancing patient care and public health outcomes.

Locations

Tampere, Pirkanmaa, Finland

Patients applied

0 patients applied

Trial Officials

Niku Oksala, MD, PhD, DSc

Principal Investigator

Tampere University, Tampere University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials